Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification

Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification

The quest for neuroprotective drugs to slow the progression of neurodegenerative diseases (NDDs), including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD), has been largely unrewarding. Preclinical evidence suggests that repurposing quetiapine, lithi...

Full description

Bibliographic Details
Main Author: Edward C Lauterbach
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Neural Regeneration Research
Subjects:
drug repositioning; neuroprotective agents; psychotropic drugs; neurodegenerative diseases; mild cognitive impairment; humans; animals; animal models
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=11;spage=1712;epage=1726;aulast=Lauterbach

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=11;spage=1712;epage=1726;aulast=Lauterbach

Similar Items